申请人:NOVO NORDISK A/S
公开号:EP0318727A2
公开(公告)日:1989-06-07
Novel aryloxyphenylpropylamines having the formula
wherein
R¹ is C₃₋₇-cycloalkyl, C₃₋₁₀-alkyl, or alkenyl which may be straight, branched or cyclic, unsubstituted or substituted with C₁₋₄-alkoxy, aryloxy or cycloalkyl or cycloalkylalkyl; and
R² is 3,4-methylenedioxyphenyl, aryl or heteroaryl, which are optionally substituted with one or more cyano, halogen, C₁₋₆-alkyl, C₁₋₆-alkoxy, C₁₋₆-alkenyl, trifluoromethyl, C₃₋₅-alkylene, aryloxy or aralkoxy
and a salt thereof with a pharmaceutically acceptable acid.
The novel compounds are useful in the treatment of anoxia, migraine, ischemia and epilepsy.
具有以下式子的新型芳氧基苯基丙胺
其中
R¹ 是 C₃₋₇-环烷基、C₃₋₁₀-烷基或烯基,可以是直链、支链或环链,未被取代或被 C₁₋₄-烷氧基、芳氧基或环烷基或环烷基烷基取代;以及
R² 是 3,4-亚甲基二氧苯基、芳基或杂芳基,它们可任选被一个或多个氰基、卤素、C-烷基、环烷基或环烷基烷基取代、C₁₋₆-烷基、C₁₋₆-烷氧基、C₁₋₆-烯基、三氟甲基、C₃₋₅-亚烷基、芳氧基或芳烷氧基取代。
及其与药学上可接受的酸的盐。
这些新型化合物可用于治疗缺氧、偏头痛、缺血和癫痫。